CRISPR Therapeutics Market Sentiment

CRISPR Therapeutics AG

CRSPNASDAQ

Trade with Public

$54.92

-0.84-1.51%

Dern. MÀJ: Sep 24, 9:30 AM

PRO

Pourquoi cela bouge-t-il ?:CRISPR Therapeutics shares are trading lower after reports that Anthropic's...

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

CRISPR Therapeutics Market Sentiment

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 22.2% short float

Options Flow▲ 0.41 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

0.41

More calls — Bullish

1,153 calls · 475 puts

Avg Consensus PT

$72

+31.5%

Highest Price Target

$120

+118.5%

Truist Securities

Lowest Price Target

$32

-41.7%

Morgan Stanley

Short Interest

22.2%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 31, 2026	Citizens	Silvan Turkcan—	+45.7%	$80 → $80	Maintained	Market Outperform
Aug 31, 2026	Needham	Gil Blum—	+49.3%	$82 → $82	Maintained	Buy
Aug 25, 2026	Citizens	Silvan Turkcan—	+45.7%	$80 → $80	Maintained	Market Outperform
Aug 4, 2026	Citigroup	Yigal Nochomovitz—	+60.2%	$82 → $88	Maintained	Buy
Jul 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+45.7%	$80 → $80	Maintained	Buy
Jul 6, 2026	Citizens	Silvan Turkcan—	+45.7%	$80 → $80	Maintained	Market Outperform
May 13, 2026	Bernstein	William Pickering—	+2.0%	$50 → $56	Maintained	Market Perform
May 6, 2026	Citigroup	Yigal Nochomovitz—	+49.3%	$80 → $82	Maintained	Buy
Mar 17, 2026	Piper Sandler	Edward Tenthoff—	+100.3%	$105 → $110	Maintained	Overweight
Feb 17, 2026	Chardan Capital	Geulah Livshits—	+38.4%	$74 → $76	Maintained	Buy
Feb 13, 2026	TD Cowen	Tyler Van Buren—	-18.1%	$40 → $45	Maintained	Hold
Feb 13, 2026	Evercore ISI Group	Liisa Bayko—	+34.7%	$62 → $74	Maintained	Outperform
Feb 13, 2026	Needham	Gil Blum—	+49.3%	$80 → $82	Maintained	Buy
Jan 30, 2026	Citizens	Silvan Turkcan—	+45.7%	$86 → $80	Maintained	Market Outperform
Dec 23, 2025	Needham	Gil Blum—	+45.7%	$80 → $80	Maintained	Buy
Dec 23, 2025	Citizens	Silvan Tuerkcan—	+56.6%	$86 → $86	Maintained	Market Outperform
Nov 26, 2025	Chardan Capital	Geulah Livshits—	+34.7%	$82 → $74	Maintained	Buy
Nov 12, 2025	Citigroup	Yigal Nochomovitz—	+40.2%	$87 → $77	Maintained	Buy
Nov 11, 2025	RBC Capital	Luca Issi—	-9.0%	$42 → $50	Maintained	Sector Perform
Nov 11, 2025	Baird	Jack Allen —	-19.9%	$52 → $44	Maintained	Neutral
Nov 10, 2025	Needham	Gil Blum—	+45.7%	$81 → $80	Maintained	Buy
Oct 17, 2025	B of A Securities	Geoff Meacham—	+69.3%	$78 → $93	Maintained	Buy
Oct 10, 2025	Needham	Gil Blum—	+47.5%	$81 → $81	Maintained	Buy
Sep 23, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+45.7%	$80 → $80	Maintained	Buy
Sep 18, 2025	JP Morgan	Brian Cheng—	+27.5%	$70	Initiate	Overweight